Menu
Back to Journals » Cancer Management and Research » Volume 4
Update on the management of invasive bladder cancer 2012
Authors Goethuys, Van Poppel H
Received 14 February 2012
Accepted for publication 31 May 2012
Published 18 July 2012 Volume 2012:4 Pages 177—182
DOI https://doi.org/10.2147/CMAR.S30850
Review by Single anonymous peer review
Peer reviewer comments 5
Hans Goethuys,1 Hein Van Poppel1,2
1Department of Urology, Ziekenhuis Oost-Limburg, Genk, Belgium; 2Department of Urology, University Hospital Leuven, Leuven, Belgium
Abstract: Muscle-invasive bladder cancer is a deadly disease for which a number of new approaches have become available to improve prognosis. A recent review emphasized the importance of timely indication of surgery and highlighted current views regarding the adequate extent of the surgery and the importance of lymph node dissection. Furthermore, treatment using neoadjuvant and adjuvant systemic chemotherapy has become more prominent, while cystectomy and diversion should be conducted only in experienced centers. Optimal methods of urinary diversion and the use of robot-assisted laparoscopic cystectomy require further study.
Keywords: bladder cancer, surgery, chemotherapy, urinary diversion
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.